degree of burns
TRANSCRIPT
-
7/29/2019 Degree of Burns
1/21
Degree of Burns
First Degree Burns: First degree burns affect
only the skin surface, also known as the
epidermis. The burn site often is red, painful
and dry. Sunburn is a good example of a first
degree burn
-
7/29/2019 Degree of Burns
2/21
Second Degree Burns: Second Degree Burns
penetrate the skin surface and involve the
next lawyer of skin tissue known as the
dermis. The urn site is often red, blistered,
swollen and painful. These burns are
frequently caused by scalding injuries from
hot fluids, flames and brief skin contact with ahot object.
-
7/29/2019 Degree of Burns
3/21
Third Degree Burns: Third Degree Burns are deepburns that destroy the outer and inner skinprotections. In these burns the epidermis anddermis tissue is destroyed. Often times in a third
degree burn in addition to skin damage, bones,tendons and muscles are also injured. The skinappears to be white or charred. In a third degreeburn nerve tissue is also damaged causing varying
amounts of pain. Like second degree burns, thirddegree burns are frequently caused by a scaldingliquid, skin that comes into contact with a hotobject, flames and electrical or chemical contact.
-
7/29/2019 Degree of Burns
4/21
-
7/29/2019 Degree of Burns
5/21
-
7/29/2019 Degree of Burns
6/21
Siklus toxoplasma gondii
Siklus hidup toxoplasma ada dua fase, yaitu
fase intestinal dan ekstraintestinal. Fase
intestinal hanya terjadi dalam intestinum
kucing. Enzim pencernaan dihasilkan
toxoplasma untuk menembus dinding
intestinum.
-
7/29/2019 Degree of Burns
7/21
Reproduksi parasit menghasilkan berjuta-juta
oocyst yang tidak infeksius, yang akan
diekskresikan bersama feses. Di luar tubuh
kucing, oocyst mengalami sporulasi
(sporogony) yang terjadi paling lama 21 hari,
dan menghasilkan oocyst infeksius.
-
7/29/2019 Degree of Burns
8/21
Pada daerah dengan suhu panas dankelembaban tinggi, oocyst dapat tahan hidupsampai satu tahun. Fase ekstraintestinal dapat
terjadi pada semua hewan atau manusia yangterinfeksi. Pada fase ini, bentuk tachyzoite(trophozoite) dapat menyebar ke berbagaiorgan melalui sirkulasi. Dalam jaringan akan
berubah menjadi zoithocyste (bradyzoite)yang dapat menjadi persisten selama hidup,menjadi bentuk infeksi khornik atau laten.
-
7/29/2019 Degree of Burns
9/21
-
7/29/2019 Degree of Burns
10/21
DIABETES MELLITUS
Insulin Dependent Diabetes(Tipe I)
Kurangnya insulin dalam jumlah besarkarena hancurnya sel beta.
Perkembangannya cepat.
Biasanya terjadi pada usia 35 tahun&kebanyakan terjadi antara usia 10-16tahun.(oleh karena juvenile diabetes).
Catatan laporan diabetik sekitar 10%.
Non Insulin DependentDiabetes(Tipe II)
Sela beta tidak menghasilkan
cukup insulin / insulin yangdihasilkan menjadi kurangefektif.
Perkembangan secaraberangsur-angsur.
Biasanya terjadi pada usia > 40tahun (oleh karena faktor usia)
Catatan laporan diabetik sekitar90%.
10
-
7/29/2019 Degree of Burns
11/21
ANTI DIABETIK ORAL
GOLONGAN ANTI DIABETIK ORAL
1. SULFONILUREA Golongan obat ini bekerja dengan cara menstimulasi
sel-sel beta di pulau langerhans pankreas untukmeningkatkan sekresi insulin.
Contoh : klorpropamid, tolbutamid, tolazamid, glimepirid,glibenklamid, glipizid, gliklazid.
2. BIGUANID
Mekanisme kerja obat ini belum diketahui dengan pasti,kemungkinan adalah dengan penghambatan glukoneogenesis
di hati & peningkatan penyerapan glukosa di jaringan perifer.
Contoh : metformin, fenformin dan buformin.
11
-
7/29/2019 Degree of Burns
12/21
3. ANALOG MEGLITINID
Bekerja dengan cara mengikat reseptor sulfonilurea &
menutup ATP-sensitive potassium chanal
Contoh : Repaglinid
4. ALFA GLUKOSIDASE INHIBITOR
obat ini bekerja dengan cara inhibisi enzim alfa glukosidase
di mukosa duodenum sehingga penguraian di/polisakaridamenjadi monosakarida dihambat.
contoh : akarbose, miglitol
5. THIAZOLIDINDION
obat ini bekerja dengan cara meningkatkan sensitivitasjaringan perifer terhadap insulin, sehingga mendorongpankreas untuk meningkatkan pelepasan insulin.
contoh : rosiglitazon, pioglitazon
12
-
7/29/2019 Degree of Burns
13/21
Significant implications of the UKPDS
findings include the following:
Glycemic control has minimal effect on
macrovascular disease risk; excess
macrovascular risk appears to be related to
conventional risk factors such as dyslipidemiaand hypertension
Sulfonylureas and insulin therapy do not
increase macrovascular disease risk
-
7/29/2019 Degree of Burns
14/21
Metformin reduces macrovascular risk in
patients who are obese[
Vigorous blood pressure control reduces
microvascular and macrovascular events; beta
blockers and angiotensin-converting enzyme
(ACE) inhibitors appear to be equally effective
in this regard
-
7/29/2019 Degree of Burns
15/21
-
7/29/2019 Degree of Burns
16/21
-
7/29/2019 Degree of Burns
17/21
-
7/29/2019 Degree of Burns
18/21
-
7/29/2019 Degree of Burns
19/21
Conventional oral hypoglycemic agents, such assulfonylurea (SU), are not suitable due to the riskof prolonged hypoglycemia; furthermore,
metformin is contraindicated for moderate toadvanced CKD
The National Kidney Foundation Kidney DiseaseOutcomes Quality Initiative guidelines
recommended that alpha-glucosidase inhibitorsshould be avoided in patients with advancedstage CKD and on dialysis
-
7/29/2019 Degree of Burns
20/21
-
7/29/2019 Degree of Burns
21/21
Cardioversion
The most common indications for
synchronized cardioversion are unstable atrial
fibrillation, atrial flutter, atrial tachycardia, and
supraventricular tachycardias.